Lentigo
Maligna
773
lentigo
maligna
to
nonsurgical
treatment.
Dermatol
Surg.
2010;36:177---84.
32.
Langley
RG,
Rajadhyaksha
M,
Dwyer
PJ,
Sober
AJ,
Flotte
TJ,.Anderson
RR.
Confocal
scanning
laser
microscopy
of
benign
and
malignant
melanocytic
skin
lesions
in
vivo.
J
Am
Acad
Dermatol.
2001;45:365---76.
33.
Weinstock
MA,
Sober
AJ.
The
risk
of
progression
of
lentigo
maligna
to
lentigo
maligna
melanoma.
Br
J
Dermatol.
1987;116:303---10.
34.
Wayte
DM,
Helwig
EB.
Melanotic
freckle
of
Hutchinson.
Cancer.
1968;21:893---911.
35.
Koh
HK,
Michalik
E,
Sober
AJ,
Lew
RA,
Day
CL,
Clark
W,
et
al.
Lentigo
maligna
melanoma
has
no
better
prognosis
than
other
types
of
melanoma.
J
Clin
Oncol.
1984;2:994---1001.
36.
Cohen
LM.
Lentigo
maligna
and
lentigo
maligna
melanoma.
J
Am
Acad
Dermatol.
1995;33:923---36.
37.
Michalik
EE,
Fitzpatrick
TB,
Sober
AJ.
Rapid
progression
of
lentigo
maligna
to
deeply
invasive
lentigo
maligna
melanoma.
Report
of
two
cases.
Arch
Dermatol.
1983;119:831---5.
38.
Kelly
JW.
Following
lentigo
maligna
may
not
prevent
the
development
of
life-threatening
melanoma.
Arch
Dermatol.
1992;128:657---60.
39.
Mc
Ewan
LE,
Buchanan
MRD.
Invasive
melanoma
in
the
donor
and
recipient
sites
of
a
Hutchinson’s
freckle
transplanted
in
a
split
skin
graft.
Aust
N
Z
J
Surg.
1986;56:81---4.
40.
Kelly
RI,
Cook
MG,
Mortimer
PS.
Aggressive
amelanotic
lentigo
lentigo
maligna.
Br
J
Dermatol.
1994;131:562---5.
41.
NNCCN
Clinical
Practice
Guidelines
in
Oncology:
Melanoma
(monograph
online).v.2.2011
[cited
2011
Ago
15].
Available
from:
http://www.nccn.org/professionals/
physician
gls/PDF/melanoma.pdf
42.
Marsden
JR,
Newton-Bishop
JA,
Burrows
L,
Cook
M,
Cox
NH,
Gore
ME,
et
al.
Revised
UK
guidelines
for
the
management
of
cutaneous
melanoma
2010.
Br
J
Dermatol.
2010;163:238---56.
43.
Arlette
J,
Trotter
M,
Trotter
T,
TTemple
C.
Management
of
lentigo
maligna
and
lentigo
maligna
melanoma:
seminars
in
surgical
oncology.
J
Surg
Oncol.
2004;86:179---86.
44.
Zalla
MJ,
Lim
KK,
Dicaudo
DJ,
Gagnot
MM.
Mohs
micrographic
excision
of
melanoma
using
immunostains.
Dermatol
Surg.
2000;26:771---84.
45.
Agarwal-Antal
N,
Bowen
GM,
Gerwels
JW.
Histologic
evalua-
tion
of
lentigo
maligna
with
permanent
sections.
J
Am
Acad
Dermatol.
2002;47:743---8.
46.
Robinson
JK.
Margin
control
for
lentigo
maligna.
J
Am
Acad
Dermatol.
1994;31:79---85.
47.
Cohen
LM,
McCall
MW,
Zax
RH.
Mohs
micrographic
surgery
for
lentigo
maligna
and
lentigo
maligna
melanoma.
A
follow-up
study.
Dermatol
Surg.
1998;24:673---7.
48.
Mohs
FE.
Chemosurgery:
a
microscopically
controlled
method
of
cancer
excision.
Arch
Surg.
1941;42:279---81.
49.
Moehrle
M,
Breuninger
H,
Röckenn
M.
A
confusing
world:
what
to
call
histology
of
three-dimensional
tumour
margins.
J
Eur
Acad
Dermatol
Venereol.
2007;21:591---5.
50.
McLeod
M,
Choudhary
S,
Giannakakis
G,
Nouri
K.
Surgical
treatments
for
lentigo
maligna:
A
review.
Dermatol
Surg.
2011;37:1210---28.
51.
Walling
HW,
Scupham
RK,
Bean
AK,
Ceilley
RI.
Staged
exci-
sion
versus
Mohs
micrographic
surgery
for
lentigo
maligna
and
lentigo
maligna
melanoma.
J
Am
Acad
Dermatol.
2007;57:659---64.
52.
Johnson
TM,
Headington
JT,
Baker
SR,
Lowe
L.
Usefulness
of
the
staged
excision
for
lentigo
maligna
and
lentigo
maligna
melanoma:
the
square
procedure.
J
Am
Acad
Dermatol.
1997;37:758---64.
53.
Anderson
KW,
Baker
SR,
Lowe
L,
Su
L,
Johnson
TM.
Treat-
ment
of
head
and
neck
melanoma,
lentigo
maligna
subtype:
A
practical
surgical
technique.
Arch
Facial
Plast
Surg.
2001;3:
202---6.
54.
Mahoney
MH,
Joseph
M,
Temple
CL.
The
perimeter
tech-
nique
for
lentigo
maligna:
an
alternative
to
Mohs
micrographic
surgery.
J
Surg
Oncol.
2005;91:120---5.
55.
Hill
DC,
Gramp
AA.
Surgical
treatment
of
lentigo
maligna
and
lentigo
maligna
melanoma.
Australas
J
Dermatol.
1999;40:25---30.
56.
Malhotra
R,
Chen
C,
Huilgol
SC,
Hill
DC,
Selva
D.
Mapped
serial
excision
for
periocular
lentigo
maligna
and
lentigo
maligna
melanoma.
Ophthalmology.
2003;110:2011---8.
57.
Bub
JL,
Berg
D,
Slee
A,
Odland
PB.
Management
of
lentigo
maligna
and
lentigo
maligna
melanoma
with
staged
excision:
a
5-year
follow-up.
Arch
Dermatol.
2004;140:552---8.
58.
Huilgol
SC,
Selva
D,
Chen
C,
Hill
DC,
James
CL,
Gramp
A,
et
al.
Surgical
margins
for
lentigo
maligna
and
lentigo
maligna
melanoma:
the
technique
of
mapped
serial
excision.
Arch
Der-
matol.
2004;140:1087---92.
59.
Jejurikar
SS,
Borschel
GH,
Johnson
TM,
Lowe
L,
Brown
DL.
Immediate,
optimal
reconstruction
of
facial
lentigo
maligna
and
melanoma
following
total
peripheral
margin
control.
Plast
Reconstr
Surg.
2007;120:1249---55.
60.
Lee
MR,
Ryman
WJ.
Treatment
of
lentigo
maligna
with
total
circumferential
margin
control
using
vertical
and
horizontal
permanent
sections:
a
retrospective
study.
Australas
J
Derma-
tol.
2008;49:196---201.
61.
Bosbous
MW,
Dzwierzynski
WW,
Neuburg
M.
Staged
excision
of
lentigo
maligna
and
lentigo
maligna
melanma:
a
10-year
experience.
Plast
Reconstr
Surg.
2009;124:1947---55.
62.
Dhawan
SS,
Wolf
DJ,
Rabinovitz
HS,
Poulos
E.
Lentigo
Maligna.
The
use
of
rush
permanent
sections
in
therapy.
Arch
Dermatol.
1990;126:928---30.
63.
Clayton
BD,
Leshin
B,
Hitchcock
MG,
Marks
M,
White
WL.
Utility
of
rush
paraffin-embedded
tangential
sections
in
the
manage-
ment
of
cutaneous
neoplasms.
Dermatol
Surg.
2000;26:671---8.
64.
Bienert
TN,
Trotter
MJ,
Arlette
JP.
Treatment
of
cutaneous
melanoma
of
the
face
by
Mohs
micrographic
surgery.
J
Cutan
Med
Surg.
2003;7:25---30.
65.
Temple
CL,
Arlette
JP.
Mohs
micrographic
surgery
in
the
treatment
of
lentigo
maligna
and
melanoma.
J
Surg
Oncol.
2006;94:287---92.
66.
Bhardwaj
SS,
Tope
WD,
Lee
PK.
Mohs
micrographic
surgery
for
lentigo
maligna
and
lentigo
maligna
melanoma
using
Mel-5
immunostaining:
University
of
Minnesota
experience.
Derma-
tol
Surg.
2006;32:690---6.
67.
Bene
NI,
Healy
C,
Coldiron
BM.
Mohs
micrographic
surgery
is
accurate
95.1%
of
the
time
for
melanoma
in
situ:
a
prospective
study
of
167
cases.
Dermatol
Surg.
2008;34:660---4.
68.
Gaudy-Marqueste
C,
Perchenet
AS,
Taséi
AM,
Madjlessi
N,
Mag-
alon
G,
Richard
MA,
et
al.
The
‘‘spaghetti
technique’’:
an
alternative
to
Mohs
surgery
or
staged
surgery
for
problematic
lentiginous
melanoma
(lentigo
maligna
and
acral
lentiginous
melanoma).
J
Am
Acad
Dermatol.
2011;64:113---8.
69.
Barlow
J,
Maize
JS,
Lang
P.
The
density
and
distribution
of
melanocytes
adjacent
to
melanoma
and
nonmelanoma
skin
cancers.
Dermatol
Surg.
2007;33:199---207.
70.
Kimyai-Asadi
A,
Ayala
GB,
Goldberg
LH,
Vujevich
J,
Jih
MH.
The
20-minute
rapid
MART-1
immunostain
for
malignant
melanoma
frozen
sections.
Dermatol
Surg.
2008;34:498---500.
71.
Cherpelis
BS,
Moore
R,
Ladd
S,
Chen
R,
Glass
LF.
Comparison
of
MART-1
frozen
sections
to
permanent
sections
using
a
rapid
19-minute
protocol.
Dermatol
Surg.
2009;35:207---13.
72.
Glass
LF,
Raziano
RM,
Clark
GS,
Higgins
HW,
Ladd
S,
Lien
MH,
et
al.
Rapid
frozen
section
immunostaining
of
melanocytes
by
microphthalmia-associated
transcription
factor.
Am
J
Der-
matopathol.
2010;32:319---23.
73.
Zalaudek
I,
Horn
M,
Richtig
E,
Hodi
S,
Keri
H,
Smolle
J.
Local
recurrence
in
melanoma
in
situ:
influence
of
sex,
age,
site
of
involvement
and
therapeutic
modalities.
Br
J
Dermatol.
2003;148:703---8.